Research and Markets: Anthrax - Pipeline Review, H2 2013 Research Report

DUBLIN--()--Research and Markets ( has announced the addition of the "Anthrax - Pipeline Review, H2 2013" report to their offering.

'Anthrax - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Anthrax, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anthrax.

Anthrax - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources


- A snapshot of the global therapeutic scenario for Anthrax.

- A review of the Anthrax products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Anthrax pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:


Anthrax Overview

Therapeutics Development

Pipeline Products for Anthrax - Overview

Pipeline Products for Anthrax - Comparative Analysis

Anthrax - Therapeutics under Development by Companies

Anthrax - Therapeutics under Investigation by Universities/Institutes

Anthrax - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Anthrax - Products under Development by Companies

Anthrax - Products under Investigation by Universities/Institutes

Anthrax - Companies Involved in Therapeutics Development

Anthrax - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Assessment by Therapeutic Class

Drug Profiles

Anthrivig - Drug Profile

NP-015 - Drug Profile

AV-7909 - Drug Profile

GC-1109 - Drug Profile

PreviThrax - Drug Profile

Recombinant Anthrax Vaccine - Drug Profile

MDX-1303 - Drug Profile

AVP-21D9 - Drug Profile

ETI-204 - Drug Profile

Anthrax Vaccine - Drug Profile

ARD-1100 - Drug Profile

MVA-BN Anthrax - Drug Profile

MU-1140 - Drug Profile

EV-021 - Drug Profile

oritavancin disphosphate - Drug Profile

CST-102 - Drug Profile

PMX-30016 - Drug Profile

AdVAV Anthrax Vaccine - Drug Profile

Epicutaneous Anthrax Vaccines - Drug Profile

SMT-15000 - Drug Profile

Subunit Vaccine For Anthrax - Drug Profile

Monoclonal Antibody For Respiratory Anthrax - Drug Profile

Anthrax Vaccine - Drug Profile

Recombinant Protective Antigen Anthrax Vaccine - Drug Profile

TP-271 - Drug Profile

PolyMap - Drug Profile

Anthrax Capsule Vaccine - Drug Profile

Vaccine Adjuvant - Drug Profile

DPX-Anthrax Vaccine - Drug Profile

MU-1140-S - Drug Profile

Metalloproteinase Inhibitors - Drug Profile

Human Antibody Based Vaccines - Drug Profile

Subunit Vaccine For Anthrax-Plague Combination - Drug Profile

SGX-204 - Drug Profile

Anthrax Program - Drug Profile

GREANX - Drug Profile

ABNV-07 - Drug Profile

W1-mAb - Drug Profile

Epimerox - Drug Profile

Snare Antibacterial For Anthrax - Drug Profile

Next Generation Anthrax Vaccines - Drug Profile

KKL-35 - Drug Profile

Anthrax - Recent Pipeline Updates

Anthrax - Dormant Projects

Anthrax - Discontinued Products

Anthrax - Product Development Milestones

Featured News & Press Releases

For more information visit

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases


Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases